NYSE$WELL

Welltower Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Welltower reported second quarter results, demonstrating strong financial performance and strategic portfolio transitions.

Welltower reported a strong second quarter, marked by a 16.7% increase in normalized FFO per share, driven by Seniors Housing Operating portfolio growth. The company completed significant investments and portfolio transitions, strengthening its balance sheet and liquidity.

  • Net income attributable to common stockholders was $0.42 per diluted share.
  • Normalized FFO attributable to common stockholders increased by 16.7% year-over-year to $1.05 per diluted share.
  • Total portfolio same-store NOI grew by 11.3%, with Seniors Housing Operating portfolio leading at 21.7%.
  • Completed $1.7 billion in pro rata gross investments, including acquisitions, loan funding, and development funding.

Headline financials

Total Revenue

$1.82B

Previous: $1.67B+9.6%
EPS (adj)

$1.05

Previous: $0.90+16.7%
Capital Expenditures

-$1.07B

Previous: -$1.1B+3.3%
Free Cash Flow

-$806M

Previous: -$997M+19.1%
Net Income

$261M

Previous: $106M+145.1%
Operating Income

$220M

Previous: $306M-28.2%
Gross Profit

$714M

Previous: $707M+1.0%
Cash & Equivalents

$2.78B

Previous: $2.2B+26.0%
Total Assets

$45.5B

Previous: $40.1B+13.7%
Stock-Based Comp

$10.4M

Previous: $10.5M-1.5%

Revenue & EPS history

Welltower · Revenue · Quarterly

$1.82B

Q2 2024+9.6%vs Q2 2023
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

Welltower · $1.2B total across 1 segment · Q3 2023

  • Resident fees and services
    $1.2B+12.7%

Forward guidance

Welltower revised its full-year net income attributable to common stockholders guidance to $1.52 to $1.60 per diluted share and increased its normalized FFO guidance to $4.13 to $4.21 per diluted share.

Tailwinds

  • Expect average blended SSNOI growth of 10.0% to 12.5%.
  • Seniors Housing Operating SSNOI growth approximately 19.0% to 23.0%.
  • Seniors Housing Triple-net SSNOI growth approximately 3.0% to 4.0%.
  • Outpatient Medical SSNOI growth approximately 2.0% to 3.0%.
  • Long-Term/Post-Acute Care SSNOI growth approximately 2.0% to 3.0%.

Headwinds

  • Earnings guidance includes only acquisitions announced or closed to date.
  • No transitions or restructures beyond those announced to date are included.
  • General and administrative expenses are anticipated to be approximately $205 million to $211 million.
  • Stock-based compensation expense is expected to be approximately $40 million.
  • Expect pro rata disposition proceeds of $643 million at a blended yield of 6.9% in the next twelve months.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

+0.7%

Avg return

Earnings day

+2.2%

Avg return

5 days after

+3.0%

Avg return

30 days after

61%

43 / 70 earnings

Positive

+9.1%

Q3 2022

Best reaction

-12.9%

Q1 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.0%+1.4%-3.9%
Q4 2025+3.5%+4.9%+3.5%
Q3 2025-1.6%-0.9%+12.9%
Q2 2025+0.6%+2.5%+4.5%
Q1 2025+1.6%+1.1%+2.7%
Q4 2024+2.2%+4.6%+3.1%
Q3 2024+5.5%+2.4%+7.0%
Q2 2024+2.2%+2.7%+10.3%
Q1 2024+1.0%+1.6%+6.7%
Q4 2023+6.6%+6.4%+4.7%
Q3 2023+2.8%+8.7%+8.4%
Q2 2023+4.4%+1.7%+2.3%
Q1 2023-0.9%+0.6%-4.7%
Q4 2022+3.0%+2.2%-9.2%
Q3 2022+9.1%+17.4%+6.6%
Q2 2022+2.1%+1.3%-6.4%
Q1 2022-0.1%+1.5%-4.4%
Q4 2021+5.3%+4.0%+15.5%
Q3 2021+2.1%+3.1%-2.9%
Q2 2021-0.6%-0.3%-2.0%
Q1 2021-0.5%+0.0%-2.2%
Q4 2020+2.7%+6.8%+16.1%
Q3 2020+1.1%+5.0%+19.5%
Q2 2020+5.9%+7.8%+14.7%
Q1 2020-12.9%-12.7%+27.8%
Q4 2019+3.3%+5.2%-39.6%
Q3 2019+1.7%+2.4%-2.4%
Q2 2019-0.3%+1.1%+6.7%
Q1 2019+2.6%+4.7%+10.6%
Q4 2018+0.2%+0.2%+0.6%
Q3 2018+0.1%-0.2%+8.3%
Q2 2018-4.1%-2.1%+2.5%
Q1 2018+4.7%+8.6%+12.6%
Q4 2017+0.8%-3.3%-3.6%
Q3 2017+1.1%+0.2%-2.7%
Q2 2017+0.8%-0.5%-1.2%
Q1 2017-0.2%+0.2%+5.6%
Q4 2016+2.9%+4.6%+4.1%
Q3 2016-2.1%-1.7%-6.9%
Q2 2016-2.7%-4.1%-4.0%
Q1 2016+5.8%
Q4 2015+4.7%
Q3 2015-1.6%
Q2 2015-1.8%
Q1 2015-1.0%
Q4 2014+3.2%
Q3 2014+0.4%
Q2 2014+1.7%
Q1 2014+1.2%
Q4 2013-0.7%
Q3 2013-2.8%
Q2 2013-0.9%
Q1 2013-1.3%
Q4 2012-2.0%
Q3 2012+1.5%
Q2 2012-3.3%
Q1 2012-1.2%
Q4 2011-2.6%
Q3 2011-4.3%
Q2 2011+5.6%
Q1 2010+0.2%
Q1 2011-0.2%
Q4 2009+1.7%
Q4 2010+1.7%
Q1 2009+1.7%
Q4 2008+1.7%
Q3 2009-4.4%
Q3 2010-4.4%
Q2 2010+0.2%
Q2 2009+0.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro